 blood infection in a premature infant in China: case report by unknown
Wu et al. BMC Research Notes 2013, 6:77
http://www.biomedcentral.com/1756-0500/6/77CASE REPORT Open AccessPichia fabianii blood infection in a premature
infant in China: case report
Yuan Wu1†, Jing Wang2†, Wenge Li1, Hongbin Jia2, Jie Che1, Jinxing Lu1, Lanzheng Liu3* and Ying Cheng1*Abstract
Background: Invasive fungal infections caused by uncommon fungi have increased in recent years. Hospitalized
low-birth-weight infants are at high risk for neonatal fungal infections. Pichia fabianii is a rare pathogen causing
blood infection, which has reportedly caused only 4 cases of fungemia and 1 case of endocarditis worldwide. Here,
we describe the first case of a P. fabianii blood infection in a premature infant in China.
Case presentation: On July 28th, a low-birth-weight (LBW, 1760 g) female infant born at 33+4 weeks of gestation
was admitted to the pediatric intensive care unit with mild neonatal asphyxia. Until August 2nd, a mechanical
respirator was used to assist respiration under the Continuous Positive Airway Pressure (CPAP) model. The baby had
an increased body temperature and a fever. To prevent infection, Ceftriaxone Sodium (CS) was administered
intravenously for three days, after which Cefepime was administered until August 13th. Chest X-rays showed
suspected plaque-like shadows in the right lung. Blood cultures twice tested positive for fungal infection caused by
Candida pelliculosa (recognized as Pichia fabianii later), which is first mis-identified by commercial kit. Hence,
intravenous fluconazole was administered. However, cultures of other body fluids (e.g., urine, feces and sputum)
tested negative for fungal infection. Routine tests and biochemistry of cerebrospinal fluid (CSF) were normal. Latex
agglutination of Cryptococcus neoformans and fungi cultures in the CSF were also negative. After 14 days of
intravenous fluconazole, blood was re-cultured, the result of which was negative. On August 30th, intravenous
fluconazole was suspended. On Sep 3rd, the infant left the hospital in good health.
Conclusions: This is the first case of a blood infection caused by P. fabianii in a LBW premature female infant in
China. Risk factors for fungal infection include premature birth, as well as mechanical invasive operation and
antibacterial drug usage. Whether such risk factors necessitate prophylactic use of antifungal drugs is an important
question that has yet to be fully addressed. Additionally, the pathogen P. fabianii collected in this study was
resistant to amphotericin B (AMB) and itraconazole (ITR). With the exception of the azole-resistant endocarditis case,
all other cases have not demonstrated such a resistance. Finally, commercial biochemical methods used in routine
practice are limited in their ability to identify P. fabianii. Molecular genetic based methods are imperative for
identification of uncommon fungal species from disseminated infections.
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Fungal infections are an increasing threat for: hospital-
ized patients using catheters (especially vascular), the
immunocompromised (e.g., patients with cancer or
HIV), premature neonates, and the elderly [1,2]. Low birth
weight (LBW, <2500 g) is particularly neonates have an in-
creased risk of fungal infection. Reports of invasive infec-
tions caused by uncommon fungi have increased in recent
years [3,4]. Pichia, teleomorph stages of several Candida
species, is an ascomycetous yeast species rarely involved
in human infections [5]. Here we describe the first case of
a fungemia caused by Pichia fabianii (also termed as Can-
dida fabianii or Lindnera fabianii) in a premature female
neonate in Beijing, China.
Case presentation
A female infant, born at 33+4 weeks of gestation, was ad-
mitted to the pediatric intensive care unit at a general
hospital in Beijing on July 28, 2010. She was diagnosed
as premature and LBW (1760 g), with mild neonatal
asphyxia. The mother was an elderly primipara (33-
years-old), with a hysteromyoma, who had developed
gestational hypertension. The mother had no history of
infectious or other underlying disease. Due to low im-
plantation of the placenta in the mother’s uterus, the
baby had been delivered via caesarean. The infant was
kept in a premature incubator (33-35°C), and was given
multi-function intensive care, as well as prohibition of
food and drink for 20 h, proper intravenous fluids
according to need, and peripheral venous hyperalimenta-
tion. A respirator was used to assist breathing until Au-
gust 2nd. To prevent infection, CS was administered
intravenously (70 mg Qd) for three days, at which point
cefepime was used instead. On August 5th, the incubator
was aborted and inspired oxygen was given. On August
11th, the infant had a fever of 37.7°C, cold hands and
feet, and a heart rate of 160-180 bpm; blood cultures
were tested and cefepime was added to 140 mg Qd. On
August 12th, chest X-Rays revealed plaque-like shadows
in the right lung. Blood, urine, feces and sputum speci-
mens were collected and sent for culturing and further
identification. Blood cultures indicated fungal infection
(Candida pelliculosa), though all other bodily fluids
tested negative in this respect. On August 13th, intraven-
ous fluconazole (10 mg per day, micro pump 5 ml/h)
treatment was begun and Cefepime treatment was
aborted. The following day, the baby’s body temperature
returned to normal and her heart rate was 148 bpm.
The urine smear test was still negative, and blood was
collected for re-examination. After treatment with intra-
venous fluconazole for 10 days, blood was retested. A
lumbar puncture was performed to get the CSF, the rou-
tine test (color, clarity, TP, Glu and CI) and biochemistry
of which was normal. A latex agglutination test ofCryptococcus neoformans and a fungi culture of the CSF
were both negative. No abnormal symptoms were found
by abdominal examination. On August 26th, blood cul-
tures came back negative. On August 30th, 18 days after
it had been begun, intravenous fluconazole administra-
tion was stopped. On September 3rd, the infant was re-
leased from the hospital in good health.
A drug sensitivity test was performed using ATB Fun-
gus3 (BioMerieux, France). The MIC of this pathogen to
5 systemic antifungals was as follows: 5-flucytosine, 5FC
(<4), amphotericin B, AMB (=1), fluconazole, FCA (≤1),
itraconazole, ITR (=2) and voriconazole, VRC (=0.125),
according to the manufacture’s procedure. The strain
was sensitive to 5FC, FCA and VRC, but resistant to
ITR, S/R to AMB following the interpretation of the sus-
ceptibility test. The yeast was sent to the laboratory in
Chinese Center for Disease Control and Prevention
(China CDC), and was cultured on Sabouraud’s Dextrose
Agar, SDA (OXOID, UK) at 25°C for 48 h. A single
white colony was picked and subcultured on a
CHROMagarCandida plate (CHROMagar, France) at
30°C for 48 h, at which point the pink-white colonies
were visible. This organism was capable of growing at
37°C and 42°C. Carbohydrate fermentations and assimi-
lations of the pathogen, performed using API 20C AUX
(BioMerieux, France), indicated high scores for C.
pelliculosa infection. Germ tube tests of this organism,
by inoculating several colonies into a bovine serum and
incubating the suspension at 37°C for 2 h, were negative.
After inoculation on meal agar with Tween 80 at 28°C
for 24 h, pseudohyphae and budding yeast could be seen.
The 26S ribosomal DNA and internal transcribed spacer
(ITS) of this organism was amplified, sequenced and
blasted, showing high similarity to P. fabianii. The uni-
versal primer pairs ITS1 (TCCGTAGGTGAACCT GCG
G) and ITS4 (TCCTCCGCTTATTGATATGC), NL (GC
ATATCAATAAGCGGAGGAAAAG) and NL-4 (GGTC
CGTGTTTCAAGACGG) were used to amplify these
two DNA fragments [6]. The GenBank accession num-
bers of ITS and 26S were JQ342083 and JQ342084, re-
spectively. MICs for AMB and ITR were re-determined
by micro-dilution methods, as described by the Clinical
and Laboratory Standards Institute (CLSI) [7] of China’s
CDC. Results showed that this pathogen was AMB and
ITR resistant, coinciding with results from the commer-
cial kit.
Conclusions
In this report, we are the first to describe the isolation of
P. fabianii from the blood culture of a LBW infant in a
Neonate Intensive Care Unit (NICU) in China. To our
knowledge, only two cases of fungemia caused by P.
fabianii in a preterm neonate have been reported world-
wide (one in the USA [3] and one in France [5]). In the
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25+3 weeks of gestation to a healthy, 33-year-old mother
[3]. This baby was given multiple courses of antibacterial
antibiotics, mechanical ventilation and central catheter
nutrition for her severe constitutional symptoms [3]. In
the second case, the female infant was born at 24 weeks
of gestation with an extremely low birth weight (ELBW,
<1000 g) [5]. Central venous catheters were placed and
cefotaxime and amikacin were used intravenously for a
week in order to remove bacteria from bodily fluids [5].
In our case, the patient was also a premature baby girl,
born at 33+4 weeks of gestation, with a LBW (1760 g). A
respirator was applied to treat the neonatal asphyxia
and antibacterial drugs were given for elevated body
temperature and presumed infection. All three cases of
neonate fungemia caused by P. fabianii occurred in a
premature female infant, who had experienced invasive
operation, and was treated with antibacterial drugs; all of
these common characteristics are incidentally risk fac-
tors for fungal infection. This begs the questions: Is anti-
fungal therapy necessary when these risk factors exist?
In one case, mechanical operations were terminated
when the fungal infection appeared and AMB was used
successfully. Whether these behaviors are more import-
ant for the recovery of the patient is unknown [3].
Three other human infection cases have been reported
[1,2,4], all of which were in adults: a 40-year-old male, a
46-year-old male, and a 53-year-old female. P. fabianii
caused endocarditis in the first patient and fungemia in
the other two. In these previously reported 5 cases (2
children, 3 adult), the organism was susceptible to AMB,
5FC and FCA, except for in the endocarditis case, in
which the pathogen developed in vitro resistance to
azoles in the course of antifungal treatment. In our case,
P. fabianii, isolated from the blood before an antifungal
was used, showed resistance to ITR and AMB. The mo-
lecular explanation for this strain’s different antifungal
susceptibility necessitates further study.
Our case further allows us to study P. fabianii and its
ability to cause invasive infection. NICU infants are a
population at risk for developing invasive candidiasis [8].
Since P. fabianii has not been included in widely used
commercial yeast diagnostic kits (API 20C AUX, ID32C
and Vitek-2), it is difficult for clinicians to properly iden-
tify and thus has been commonly misidentified as P.
anomala or C. utilis [9] only using commercial kit. In this
study, the pathogen was initially identified as C. pelliculosa
by API 20C AUX kit. And according to the molecular
method mentioned in previous reports [1-4], the se-
quences of ITS region and D1/D2 variable region of the
26S rDNA were sequenced and BLAST in GenBank. The
pathogen was subsequently identified as P. fabianii.
In summary, we report the first case of blood infection
caused by P. fabianii of a LBW premature female infantin China. Because preterm birth, mechanical invasive
operation, and usage of antibacterial drugs are risk fac-
tors for fungal infection, the prophylactic use of antifun-
gal drugs should be considered under such risk factors.
The pathogen P. fabianii collected in this study was re-
sistant to AMB and ITR; this resistance was not present
in any other cases of P. fabianii except the endocarditis
case, in which the pathogen was resistant to azoles [3].
Molecular genetic based methods are imperative for fu-
ture identification of uncommon fungal species from
disseminated infections.
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